NS38372/NS/NINDS NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1999	1
2000	4
2002	8
2003	2
2004	3
2005	2
2006	2
2007	6
2008	5
2009	3
2010	1
2011	2
2012	1
2024	0

1

Network-level neuroplasticity in cortico-basal ganglia pathways.

Graybiel AM. Graybiel AM. Parkinsonism Relat Disord. 2004 Jul;10(5):293-6. doi: 10.1016/j.parkreldis.2004.03.007. Parkinsonism Relat Disord. 2004. PMID: 15196508 Review.

2

The basal ganglia: learning new tricks and loving it.

Graybiel AM. Graybiel AM. Curr Opin Neurobiol. 2005 Dec;15(6):638-44. doi: 10.1016/j.conb.2005.10.006. Epub 2005 Nov 3. Curr Opin Neurobiol. 2005. PMID: 16271465 Review.

3

Striosomes and mood dysfunction in Huntington's disease.

Tippett LJ, Waldvogel HJ, Thomas SJ, Hogg VM, van Roon-Mom W, Synek BJ, Graybiel AM, Faull RL. Tippett LJ, et al. Brain. 2007 Jan;130(Pt 1):206-21. doi: 10.1093/brain/awl243. Epub 2006 Oct 12. Brain. 2007. PMID: 17040921 Clinical Trial.

4

Imaging amyloid deposition in Lewy body diseases.

Gomperts SN, Rentz DM, Moran E, Becker JA, Locascio JJ, Klunk WE, Mathis CA, Elmaleh DR, Shoup T, Fischman AJ, Hyman BT, Growdon JH, Johnson KA. Gomperts SN, et al. Neurology. 2008 Sep 16;71(12):903-10. doi: 10.1212/01.wnl.0000326146.60732.d6. Neurology. 2008. PMID: 18794492 Free PMC article.

5

Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity.

Yeger-Lotem E, Riva L, Su LJ, Gitler AD, Cashikar AG, King OD, Auluck PK, Geddie ML, Valastyan JS, Karger DR, Lindquist S, Fraenkel E. Yeger-Lotem E, et al. Nat Genet. 2009 Mar;41(3):316-23. doi: 10.1038/ng.337. Epub 2009 Feb 22. Nat Genet. 2009. PMID: 19234470 Free PMC article.

6

A single amino acid substitution differentiates Hsp70-dependent effects on alpha-synuclein degradation and toxicity.

Klucken J, Shin Y, Hyman BT, McLean PJ. Klucken J, et al. Biochem Biophys Res Commun. 2004 Dec 3;325(1):367-73. doi: 10.1016/j.bbrc.2004.10.037. Biochem Biophys Res Commun. 2004. PMID: 15522241

7

Rapid-onset dystonia-parkinsonism: linkage to chromosome 19q13.

Kramer PL, Mineta M, Klein C, Schilling K, de Leon D, Farlow MR, Breakefield XO, Bressman SB, Dobyns WB, Ozelius LJ, Brashear A. Kramer PL, et al. Ann Neurol. 1999 Aug;46(2):176-82. doi: 10.1002/1531-8249(199908)46:2<176::aid-ana6>3.0.co;2-2. Ann Neurol. 1999. PMID: 10443882

8

Alpha-synuclein and chaperones in dementia with Lewy bodies.

Cantuti-Castelvetri I, Klucken J, Ingelsson M, Ramasamy K, McLean PJ, Frosch MP, Hyman BT, Standaert DG. Cantuti-Castelvetri I, et al. J Neuropathol Exp Neurol. 2005 Dec;64(12):1058-66. doi: 10.1097/01.jnen.0000190063.90440.69. J Neuropathol Exp Neurol. 2005. PMID: 16319716

9

Dysregulation of CalDAG-GEFI and CalDAG-GEFII predicts the severity of motor side-effects induced by anti-parkinsonian therapy.

Crittenden JR, Cantuti-Castelvetri I, Saka E, Keller-McGandy CE, Hernandez LF, Kett LR, Young AB, Standaert DG, Graybiel AM. Crittenden JR, et al. Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2892-6. doi: 10.1073/pnas.0812822106. Epub 2009 Jan 26. Proc Natl Acad Sci U S A. 2009. PMID: 19171906 Free PMC article.

10

Tyrosine and serine phosphorylation of alpha-synuclein have opposing effects on neurotoxicity and soluble oligomer formation.

Chen L, Periquet M, Wang X, Negro A, McLean PJ, Hyman BT, Feany MB. Chen L, et al. J Clin Invest. 2009 Nov;119(11):3257-65. doi: 10.1172/JCI39088. Epub 2009 Oct 12. J Clin Invest. 2009. PMID: 19855133 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

37 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year